All three papers are by Peter Rothwell of University of Oxford and John Radcliffe Hospital, and colleagues.

WSJ: Studies Find New Evidence Aspirin May Prevent Cancer

Taking low-dose aspirin for five years halves the risk of developing colon cancer, according to data published two years ago by Peter Rothwell, from Oxford University.

BBC: Aspirin a 'no brainer' against cancer after screening

In a series of papers in the Lancet, the team, led by Professor Peter Rothwell found that a daily low dose of the cheap drug cut the risk of a range of cancers, and could even treat the disease.

BBC: Should I take aspirin?

All three papers are by Professor Peter M Rothwell, University of Oxford and John Radcliffe Hospital, Oxford, and colleagues.

FORBES: Meta-Analysis Adds New Evidence For Cancer Benefits Of Daily Aspirin